Wednesday, June 10, 2026

biotech Β· PTSD - Post Traumatic Stress Disorder Β· P1b: Advanced Solid Tumors Β· CMPX

Compass Therapeutics

Compass Therapeutics trial registry β€” 23 ClinicalTrials.gov studies with program phase, status, and indication context.

80 Guest Street, Suite 601, Boston, MA 02135, US HQ
2014 Founded
54 Employees
Public company Type
CMPX Β· NYSE Ticker
Company details
Status
Public
HQ
80 Guest Street, Suite 601, Boston, MA 02135, US
Founded
2014
Employees
54
Programs
15
Drugs
3
Patents
100
Intelligence Β· Clinical Trials

Compass Therapeutics clinical trials

Registry index of 23 ClinicalTrials.gov studies linked to Compass Therapeutics programs β€” each row shows trial ID, program name, phase, status, and indication.

Compass Therapeutics trial registry β€” 23 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Compass Therapeutics.

  1. Psilocybin β€” Phase 2

    Clinical update
  2. Psilocybin β€” Phase 3

    Clinical update
  3. CTX-10726 β€” Phase 1

    Clinical update
  4. COMP360 psilocybin β€” Phase 3

    Clinical update
  5. CTX-009 β€” Phase 3

    Clinical update
  6. Psilocybin β€” Phase 3

    Clinical update
  7. CTX-009 β€” Phase 2

    Clinical update
  8. CTX-009 β€” Phase 2

    Clinical update

Trial registry

23 studies